Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

Adapt Pharma successfully completes pharmacokinetic study of intranasal naloxone

April 24, 2015

FDA approves filgrastim for myelosuppression in acute radiation injury

April 23, 2015

Tamoxifen found to inhibit the effects of amphetamine

April 21, 2015

Northeastern University patents CB1 receptor modulators

March 12, 2015

Substance abuse candidate GS-6637 well tolerated in healthy volunteers

March 10, 2015

Reversible change in enzyme's substrate specificity accelerates elimination of toxic acetaldehyde

Feb. 27, 2015

Cerecor acquires kappa opioid receptor antagonist from Eli Lilly

Feb. 23, 2015

Pluristem Therapeutics reports results for PLX-R18 in animal model of ARS

Feb. 18, 2015

Elite Pharmaceuticals plans phase III trial of abuse-deterrent opioid

Feb. 18, 2015

FDA grants fast track designation to intranasal naloxone treatment

Feb. 18, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...